BioNexus Gene Lab
BGLC
#10082
Rank
$4.11 M
Marketcap
$0.23
Share price
-14.59%
Change (1 day)
-60.53%
Change (1 year)

BioNexus Gene Lab (BGLC) Fails to deliver data

Key failure to deliver metrics for BioNexus Gene Lab:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioNexus Gene Lab (BGLC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioNexus Gene Lab (BGLC) - since 2023

Volume in USD (price x number of shares), data since 2023

BioNexus Gene Lab (BGLC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$0.91 M-77%
2023$3.99 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
$1 M$6 M๐Ÿ‡บ๐Ÿ‡ธ USA